Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (8): 63-71.doi: 10.6040/j.issn.1671-7554.0.2022.1479
Previous Articles Next Articles
LIU Teng, MA Yingchun
CLC Number:
[1] Matteson KA, Robison K, Jacoby VL. Opportunities for early detection of endometrial cancer in women with postmenopausal bleeding[J]. JAMA Intern Med, 2018, 178(9): 1222-1223. [2] Ledford LRC, Lockwood S. Scope and epidemiology of gynecologic cancers: an overview[J]. Semin Oncol Nurs, 2019, 35(2): 147-150. [3] Chen S, Wang LL, Sun KX, et al. LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(9 Pt B): 3013-3021. [4] 王铭洋, 范文生, 叶明侠, 等. 子宫内膜癌分子分型及临床应用研究进展[J]. 现代妇产科进展, 2021, 30(4): 307-310, 313. [5] Bell DW, Ellenson LH. Molecular genetics of endometrial carcinoma[J]. Annu Rev Pathol, 2019, 14: 339-367. doi: 10.1146/annurev-pathol-020117-043609. [6] Pedersen CB, Nielsen FC, Rossing M, et al. Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing[J]. Mol Oncol, 2018, 12(12): 2136-2146. [7] Vasaikar S, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types[J]. Nucleic Acids Res, 2018, 46: D956-D963. [8] Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun, 2019, 10(1): 1523. [9] Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. A review[J]. J Reprod Med, 2002, 47(3): 173-190. [10] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30. [11] Arend RL, Jones BA, Martinez A, et al. Endometrial cancer: molecular markers and management of advanced stage disease[J]. Gynecol Oncol, 2018, 150(3): 569-580. [12] Piulats JM, Guerra E, Gil-Martín M, et al. Molecular approaches for classifying endometrial carcinoma[J]. Gynecol Oncol, 2017, 145(1): 200-207. [13] Nuñez-Olvera SI, Gallardo-Rincón D, Puente-Rivera J, et al. Autophagy machinery as a promising therapeutic target in endometrial cancer[J]. Front Oncol, 2019, 9: 1326. doi: 10.3389/fonc.2019.01326. [14] Raffone A, Travaglino A, Mascolo M, et al. Histopathological characterization of ProMisE molecular groups of endometrial cancer[J]. Gynecol Oncol, 2020, 157(1): 252-259. [15] Xu D, Wang Y, Wu J, et al. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway[J]. Cell Death Dis, 2021, 12(2): 162. [16] Zhang H, Geng Y, Sun C, et al. Upregulation of ECT2 predicts adverse clinical outcomes and increases 5-fluorouracil resistance in gastric cancer patients[J]. J Oncol, 2021, 2021: 2102890. doi: 10.1155/2021/2102890. [17] Wang H, Liu H, Li J, et al. Effect of ECT2 expression on the growth of triple-negative breast cancer cells with paclitaxel intervention[J]. Onco Targets Ther, 2020, 13: 12905-12918. doi: 10.2147/OTT.S275725. [18] Yang Q, Yu B, Sun J. TTK, CDC25A, and ESPL1 as prognostic biomarkers for endometrial cancer[J]. Biomed Res Int, 2020, 2020: 4625123. doi: 10.1155/2020/4625123. [19] Liu J, Wu Z, Sun R, et al. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA[J]. Life Sci, 2020, 258: 118231. doi: 10.1016/j.lfs.2020.118231. [20] Li L, Xu DB, Zhao XL, et al. Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer[J]. Arch Gynecol Obstet, 2013, 288(1): 155-165. [21] Laine A, Nagelli SG, Farrington C, et al. CIP2A interacts with TopBP1 and drives basal-like breast cancer tumorigenesis[J]. Cancer Res, 2021, 81(16): 4319-4331. [22] Cao C, Han P, Liu L, et al. Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability[J]. J Biol Chem, 2021, 297(3): 101036. [23] Bai X, Yi M, Xia X, et al. Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA[J]. Cancer Manag Res, 2018, 10: 4039-4050. doi: 10.2147/CMAR.S170033. [24] Sun BY, Wei QQ, Liu CX, et al. ECT2 promotes proliferation and metastasis of esophageal squamous cell carcinoma via the RhoA-ERK signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2020, 24(15): 7991-8000. [25] Tong N, He Z, Ma Y, et al. Tumor associated macrophages, as the dominant immune cells, are an indispensable target for immunologically cold tumor-glioma therapy?[J]. Front Cell Dev Biol, 2021, 9: 706286. doi: 10.3389/fcell.2021.706286. [26] 许欣, 张颖, 陈超. 免疫细胞在子宫内膜癌中作用的研究进展[J]. 医学综述, 2021, 27(23): 4656-4660. XU Xin, ZHANG Ying, CHEN Chao. Research progress on the role of immune cells in endometrial cancer[J]. Medical Recapitulate, 2021, 27(23): 4656-4660. [27] Crumley S, Kurnit K, Hudgens C, et al. Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes[J]. Mod Pathol, 2019, 32(3): 396-404. [28] Xu D, Wang Y, Wu J, et al. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway[J]. Cell Death Dis, 2021, 12(2): 162. [29] Szczerba BM, Castro-Giner F, Vetter M, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression[J]. Nature, 2019, 566(7745): 553-557. |
[1] | ZHANG Zhaoying, MA Chunhong. Immunomodulatory effects of bile acid in hepatointestinal diseases [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 30-36. |
[2] | QIAO Chong, WANG Tingting. Research progress of maternal-fetal immunomodulatory mechanism [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 24-31. |
[3] | WANG Yan, ZHANG Yuhui, HU Naibo, TENG Guangshuai, ZHOU Yuan, BAI Jie. Characteristics of bone marrow immune microenvironment in patients with acute myeloid leukemia based on single-cell RNA sequencing [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 32-40. |
[4] | LI Wenqing, YE Lan, JIANG Yuhua. CDK7 inhibitor THZ1 increases the radiosensitivity of human glioma cell line U251 [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 8-13. |
[5] | TIAN Baorui, ZHANG Yongchao, HAN Xiaoyang, TIAN Yingying, WANG Chuanxi. Prediction of the association between genes and glioblastoma based on databases [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 8-13. |
[6] | CUI Ximing, WANG Shuang, XU Shunjiang, ZHANG Rui, XIE Bing, CUI Dongsheng, ZHAO Zhansheng. Effect of resveratrol on the proliferation of human retinal capillary endothelial cells induced by high glucose and its possible mechanism [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 19-24. |
[7] | YAN Huili, WEI Muyun, YAN Lei, ZHAO Yueran. Effect of FK506 binding protein 52 on proliferation of human endometrial stromal cells [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 80-87. |
[8] | CHEN Yan, LIU Juan, CHEN Hanxiang, ZHANG Weifang, ZHAO Weiming. Effects of miR-17 on the senescence of human foreskin fibroblasts [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 55-59. |
[9] | LI Tao, WU Hongxi, ZHANG Yongchao, ZHENG Zhiming, ZHANG Zhen, TENG Liangzhu. The inhibitory effect of nitidine chloride on pituitary adenoma GH3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(10): 6-10. |
[10] | LI Mei-ying1, LI Ji-sheng1, YU Xue-jun1, SUN Li-mei1, WANG Ai-jun1, LIU Qi-ji2, WANG Xiu-wen1. Effects of bufalin on the proliferation and cell cycle of human pancreatic cancer CAPAN-2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 37-41. |
[11] | TIAN Tian-tian1, LI Ji-sheng1, WANG Ya-wei1, MA Dao-xin2, WANG Xiu-wen1. Genistein exerts antitumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 44-48. |
[12] | ZHU Zu-an1, FEI Su-juan1, LIU Lei2, ZHANG Qiu-yue1, SUN Min1, LIU Ying2. Effect of SKI-II on SGC7901 cell cycle by inhibiting the Sphk1 expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 70-74. |
[13] | ZENG Zhao-qing1,2, DU Wen-jun2, SHI Zhao-zhang2, XU Wei3, LIU Qian-wen3, CHEN Shi-jun4. Effect of the interlukin-17 on proliferation and cell cycle of the hepatic stellate cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 21-24. |
[14] | WANG Rui-jie1, XU Hong-zhi1, HUANG Min3, MA Chun-yan2, SUI Xiao-hui1, LIU Xin1, ZHANG Bing-chang3, LI Yuan-tang3. Cell cycle distributions and cell proliferation-related protein expression in myelodysplastic syndromes, aplastic anemia, and acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(2): 97-101. |
[15] | CHEN Shi-min1,2, XIN Jia-xuan1, XU Chun-xiao1, LIU Bin1, SUN Xiao-ming2, HU Cheng-jin2, LIU Xian-xi1. Effects of UbcH10 expression on proliferation of colorectal cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 35-38. |
|